当前位置:首页 - 行情中心 - 君实生物-U(688180) - 财务分析 - 资产负债表

君实生物-U

(688180)

  

流通市值:188.80亿  总市值:243.96亿
流通股本:7.63亿   总股本:9.86亿

资产负债表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
流动资产:
货币资金3,788,193,376.774,169,024,334.664,881,481,873.95,015,956,414.34
应收票据及应收账款483,226,004.74365,652,777.94487,862,881.29300,077,645.72
应收账款483,226,004.74365,652,777.94487,862,881.29300,077,645.72
预付款项238,897,466.48284,598,902.69249,922,233.85362,994,097.67
其他应收款合计374,008,655.7792,199,663.3647,122,194.3426,416,655.25
存货538,052,813.07747,921,947.45652,530,730.01580,242,538.5
一年内到期的非流动资产8,184,311.36353,156.052,208,866.693,731,190.69
其他流动资产140,512,460.52123,196,271.26102,376,277.9101,947,690.85
流动资产平衡项目0000
流动资产合计5,571,075,088.715,782,947,053.416,423,505,057.986,791,366,233.02
非流动资产:
长期股权投资242,575,715.18442,385,832.46460,333,741.39477,013,159.18
其他权益工具投资84,184,097.9166,915,988.1576,888,211.42117,129,486.55
其他非流动金融资产806,351,904.77861,489,120.91772,121,230763,762,575.27
固定资产2,431,855,834.522,069,748,582.551,926,591,034.441,842,638,096.38
在建工程1,325,356,972.041,399,890,690.211,208,033,461.541,146,669,677.21
使用权资产51,367,618.5857,183,284.8665,063,156.2273,320,237.52
无形资产546,964,593.08371,568,981.52311,195,148.57311,796,097.16
长期待摊费用12,598,552.1416,363,473.1220,207,977.6721,778,830.53
递延所得税资产103,396,116.17177,094,436.22172,690,349.96226,261,011.1
其他非流动资产167,140,378.23341,556,777.98342,847,517.76359,193,072.38
非流动资产平衡项目0000
非流动资产合计5,771,791,782.625,804,197,167.985,355,971,828.975,339,562,243.28
资产平衡项目0000
资产总计11,342,866,871.3311,587,144,221.3911,779,476,886.9512,130,928,476.3
流动负债:
短期借款452,435,151.72339,522,714.95345,033,305.73353,115,329.47
应付票据及应付账款1,385,817,163.161,107,760,481.481,163,798,877.671,057,159,184.87
其中:应付票据4,672,296.11---
应付账款1,381,144,867.051,107,760,481.481,163,798,877.671,057,159,184.87
合同负债146,298,445.2782,076,543.239,621,451.9933,048,509.99
应付职工薪酬234,201,628.25154,587,493.3138,690,868.9159,852,281.79
应交税费50,741,556.7920,867,233.9424,518,963.2224,276,808.05
其他应付款合计37,330,788.8239,686,430.6532,386,429.0933,608,853.04
一年内到期的非流动负债122,886,665.63105,191,474.1994,737,776.695,877,678.19
其他流动负债8,686,175.9130,417.0753,817.0268,419.45
流动负债平衡项目0000
流动负债合计2,438,397,575.551,849,722,788.781,838,841,490.221,757,007,064.85
非流动负债:
长期借款1,195,794,059.521,044,110,933.42936,898,939.76904,228,351.43
租赁负债17,451,499.8525,229,668.9230,196,087.5338,739,262.66
预计负债27,104,611.58---
递延收益183,463,569.04171,740,811.4169,575,031.99150,802,309.07
其他非流动负债160,045,083.81158,641,344.9218,455,640.925,773,976.09
非流动负债平衡项目0000
非流动负债合计1,583,858,823.81,399,722,758.661,155,125,700.21,099,543,899.25
负债平衡项目0000
负债合计4,022,256,399.353,249,445,547.442,993,967,190.422,856,550,964.1
所有者权益(或股东权益):
实收资本(或股本)985,689,871985,689,871985,689,871985,689,871
资本公积15,394,559,338.215,396,546,310.5415,388,019,121.5915,379,468,607.96
减:库存股26,891,299.0815,029,726.92--
其他综合收益-142,066,958.6-119,141,263.5-106,586,674.39-95,855,782.11
未分配利润-9,060,066,765.05-8,183,453,307.53-7,774,047,311.28-7,320,067,208.53
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计7,151,224,186.478,064,611,883.598,493,075,006.928,949,235,488.32
少数股东权益169,386,285.51273,086,790.36292,434,689.61325,142,023.88
股东权益平衡项目0000
股东权益合计7,320,610,471.988,337,698,673.958,785,509,696.539,274,377,512.2
负债和股东权益合计11,342,866,871.3311,587,144,221.3911,779,476,886.9512,130,928,476.3
公告日期2024-03-292023-10-282023-08-312023-04-29
审计意见(境内)标准无保留意见
TOP↑